Clinical outcomes and associated factors of radioiodine-131 treatment in differentiated thyroid cancer with cervical lymph node metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical outcomes and associated factors of radioiodine-131 treatment in differentiated thyroid cancer with cervical lymph node metastasis

Published:2018-03-15 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Cao Chung‑Jie¹,Dou Cheng‑Yun²,Lian Jiayan¹,Luan Zhao‑Sheng³,Zhou Wen³,Xie Wenlin¹,Chen Li⁴,Zhou Kehua⁴,Lai Hong⁴

Affiliation:

1. Department of Pathology, The First Affiliated Hospital of Sun Yat‑Sen University, Guangzhou, Guangdong 510080, P.R. China

2. Department of Hepatology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China

3. Department of Nuclear Medicine, PLA 88 Hospital, Taian, Shandong 271000, P.R. China

4. Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of response to Radioactive Iodine Therapy in Intermediate and high risk patients with papillary thyroid carcinoma;BMC Endocrine Disorders;2024-07-15

2. A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate‑ and high‑risk differentiated thyroid cancer patients: a bi-center retrospective study;Endocrine;2023-12-12

3. Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer;Archives of Endocrinology and Metabolism;2023-01-18

4. Histology is more ιmportant than persistent anti‐Tg antibodies for progression of differentiated thyroid cancer;Clinical Endocrinology;2021-03-21

5. Clinical predictors of I-131 therapy failure in differentiated thyroid cancer by machine learning: A single-center experience;World Journal of Nuclear Medicine;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3